The semiconductor industry is experiencing rapid growth, driven by an increase in demand due to rapid technological advancements. This surge in demand presents a significant opportunity for investors, ...
Genmab A/S (NASDAQ:GMAB), a Denmark-based biotechnology company with a market capitalization of $13.4 billion, announced today that it has granted restricted stock units and warrants to its employees.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback